Genetic and Protein Markers Related to in situ Growth and Multiplicity in Small Sporadic Colorectal Adenomas

T. LøvigInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, NorwayCorrespondence[email protected]

L. ThorstensenInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, Norway

B. HofstadInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, Norway

S. Norheim AndersenInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, Norway

O. P. Fraas ClausenInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, Norway

M. VatnInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, Norway

R. A. LotheInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, Norway

T. O. RognumInstitute of Forensic Medicine, The National Hospital, University of Oslo; Institute of Pathology, The National Hospital, University of Oslo; Medical Dept., The National Hospital, University of Oslo; Dept. of Genetics, Institute for Cancer Research, Norwegian Radium Hospital; and Medical Dept., Ullevål University Hospital, Oslo, Norway

show all

Abstract

Background: Some early genetic events in the development of colorectal adenomas are known, but their relationship to in vivo growth characteristics is uncertain. This study compared in situ size changes and other clinicopathological variables with selected genetic and protein markers. Methods: 56 adenomas (≤10 mm) from 39 patients were analysed for APC, CTNNBI and K-ras mutations, allelic imbalance on 1p and 18q, microsatellite instability and immunohistochemical expression of HLA-DR, BAX, BCL-2 and Ki-67. For 42 of the adenomas, in situ growth was measured over 3 years. The total number of polyps in each patient was recorded. Results: K-ras was mutated in 8/56 adenomas. None of the regressing adenomas revealed such mutations, compared to 20% in those that maintained or increased their size. Multivariate linear regression analysis showed that tumour growth was higher in females compared to males, and was even higher in the presence of a K-ras mutation. APC mutations were found in 37/56 adenomas. CTNNBI mutations were found in 2/19 adenomas without APC mutation. Deletions of 1p were found in 12/56 adenomas and, seemingly, most frequent in patients with few tumours. The most frequently expressed protein was BAX (33/41), but neither this nor the other proteins showed associations with an in situ growth pattern. Conclusion: The multivariate linear regression model showed that patient gender and the presence of K-ras mutation had significant effects on tumour growth. The lack of the proliferative stimulus resulting from a K-ras mutation may contribute to the process of adenoma regression.

Key words:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Genetic and Protein Markers Related to in situ Growth and Multiplicity in Small Sporadic Colorectal Adenomas

Information for

Open access

Opportunities

Help and information

Genetic and Protein Markers Related to in situ Growth and Multiplicity in Small Sporadic Colorectal Adenomas

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature